HUP0303632A2 - Eljárások kettős szálú DNS célszekvenciák tisztítására és detektálására hármas hélix kölcsönhatás alkalmazásával - Google Patents

Eljárások kettős szálú DNS célszekvenciák tisztítására és detektálására hármas hélix kölcsönhatás alkalmazásával

Info

Publication number
HUP0303632A2
HUP0303632A2 HU0303632A HUP0303632A HUP0303632A2 HU P0303632 A2 HUP0303632 A2 HU P0303632A2 HU 0303632 A HU0303632 A HU 0303632A HU P0303632 A HUP0303632 A HU P0303632A HU P0303632 A2 HUP0303632 A2 HU P0303632A2
Authority
HU
Hungary
Prior art keywords
stranded dna
triple helix
purifying
target sequences
methods
Prior art date
Application number
HU0303632A
Other languages
English (en)
Inventor
Francis Blanche
Béatrice Cameron
Original Assignee
Gencell S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0103953A external-priority patent/FR2822476B1/fr
Application filed by Gencell S.A. filed Critical Gencell S.A.
Publication of HUP0303632A2 publication Critical patent/HUP0303632A2/hu
Publication of HUP0303632A3 publication Critical patent/HUP0303632A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6839Triple helix formation or other higher order conformations in hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány tárgyát képezik egy harmadik DNS-szállal kölcsönhatásbalépni és stabil hármas hélixet kialakítani képes új kettős szálú DNS-célszekvenciák. A találmány tárgyát képezi ezen túl egy kettős szálúDNS-molekula tisztítására szolgáló eljárás, amely során az említettDNS-molekulát tartalmazó oldatot érintkeztetik egy harmadik DNS-szállal, amely képes hibridizáció révén egy hármas hélix szerkezetetlétrehozni az említett DNS-molekula által hordozott, kettős szálú DNS-célszekvenciával. Ó
HU0303632A 2001-03-23 2002-03-25 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction HUP0303632A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0103953A FR2822476B1 (fr) 2001-03-23 2001-03-23 Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
US28527201P 2001-04-23 2001-04-23
PCT/FR2002/001034 WO2002077274A2 (fr) 2001-03-23 2002-03-25 Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice.

Publications (2)

Publication Number Publication Date
HUP0303632A2 true HUP0303632A2 (hu) 2004-01-28
HUP0303632A3 HUP0303632A3 (en) 2005-12-28

Family

ID=26212934

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303632A HUP0303632A3 (en) 2001-03-23 2002-03-25 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction

Country Status (13)

Country Link
EP (1) EP1370692A2 (hu)
JP (1) JP4444564B2 (hu)
KR (2) KR20030088464A (hu)
CN (1) CN1498276A (hu)
BR (1) BR0208292A (hu)
CA (1) CA2440133A1 (hu)
HU (1) HUP0303632A3 (hu)
IL (2) IL158017A0 (hu)
MX (1) MXPA03008642A (hu)
NO (1) NO20034184L (hu)
NZ (1) NZ528507A (hu)
PL (1) PL365208A1 (hu)
WO (1) WO2002077274A2 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1737945T1 (sl) 2004-04-19 2011-05-31 Aventis Pharma Sa Postopek za čiščenje plazmidne DNA
MX2012005217A (es) * 2009-11-06 2012-07-23 Univ Hong Kong Chinese Analisis genomico a base de tamaño.
EP2407552B1 (en) * 2010-07-13 2012-11-14 Cnrs Method for the isolation of the proteins bound to any kind of interesting nucleic acid sequence
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US11248257B2 (en) 2017-08-25 2022-02-15 Zoetis Services Llc Method of immobilizing a nucleic acid probe to a solid support
CN109959691B (zh) * 2019-04-15 2021-06-08 济南大学 一种基于级联光电活性材料和三螺旋分子开关检测核酸的方法
CN116396963B (zh) * 2023-04-12 2023-10-13 南通大学 一类抑制血管内皮生长因子a表达的三链形成寡核苷酸及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011390A1 (en) * 1990-12-17 1992-07-09 Idexx Laboratories, Inc. Nucleic acid sequence detection by triple helix formation
FR2728264B1 (fr) * 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
FR2776669B1 (fr) * 1998-03-24 2001-06-15 Rhone Poulenc Rorer Sa Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Also Published As

Publication number Publication date
BR0208292A (pt) 2004-04-13
HUP0303632A3 (en) 2005-12-28
WO2002077274A2 (fr) 2002-10-03
MXPA03008642A (es) 2004-06-30
KR20030088464A (ko) 2003-11-19
JP4444564B2 (ja) 2010-03-31
JP2004523245A (ja) 2004-08-05
NO20034184L (no) 2003-11-04
PL365208A1 (en) 2004-12-27
NO20034184D0 (no) 2003-09-19
IL158017A (en) 2011-07-31
KR101002499B1 (ko) 2010-12-17
CN1498276A (zh) 2004-05-19
AU2002253261C1 (en) 2002-10-08
WO2002077274A3 (fr) 2003-10-02
KR20090094870A (ko) 2009-09-08
AU2002253261C9 (en) 2002-10-08
IL158017A0 (en) 2004-03-28
EP1370692A2 (fr) 2003-12-17
NZ528507A (en) 2005-08-26
CA2440133A1 (fr) 2002-10-03

Similar Documents

Publication Publication Date Title
Koslowsky et al. Guide RNAs for transcripts with developmentally regulated RNA editing are present in both life cycle stages of Trypanosoma brucei
AU2001254794A1 (en) Diagnosis of diseases associated with dna adducts
WO2003027326A3 (en) Nucleic acid sequencing by raman monitoring of molecular deconstruction
WO2003012052A3 (en) Specific inhibition of gene expression by small double stranded rnas
DE60123980D1 (de) Amplifizierung von nukleinsäuresequenzen mittels multiplex priming
WO2006047842A3 (en) Modified nucleosides for rna interference
WO2002002807A8 (en) Diagnosis of diseases associated with cell signalling
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP2366803A3 (en) Compositions and methods for detecting west nile virus
WO2001068912A3 (en) Diagnosis of diseases associated with tumor suppressor genes and oncogenes
WO2005021786A8 (en) A method of sequencing nucleic acids by ligation of labelled oligonucleotides
HUP0303632A2 (hu) Eljárások kettős szálú DNS célszekvenciák tisztítására és detektálására hármas hélix kölcsönhatás alkalmazásával
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2002046454A3 (de) Diagnose von mit angiogenese assoziierten krankheiten durch bestimmung der methylierung von mit angiogenese assoziierten genen
WO2002036814A3 (de) Diagnose von mit cdk4 assoziierten krankheiten durch bestimmung des methylierungszustandes des cdk4
ATE223499T1 (de) Von kreisförmiger matrize abhängige kettenreaktion
Komissarova et al. Inhibition of a transcriptional pause by RNA anchoring to RNA polymerase
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2002046468A3 (en) Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
BR0316224A (pt) Sequência de dna da região genÈmica tcd de photorhabdus luminescens
EP2371970A3 (fr) Procédés de purification et de détection de séquences cibles d'ADN double brin par intéraction triple hélice
HUP0302565A2 (hu) Eljárás tripla hélix formáció tisztítására immobilizált oligonukleotidon
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2002253261B2 (en) Methods for purifying and detecting double stranded DNA target sequences by triple helix interaction

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

FH92 Termination of representative

Representative=s name: RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVI, HU

GB9A Succession in title

Owner name: AVENTIS PHARMA S.A., FR

Free format text: FORMER OWNER(S): GENCELL S.A., FR; CENTELION, FR

HC9A Change of name, address

Owner name: AVENTIS PHARMA S.A., FR

Free format text: FORMER OWNER(S): GENCELL S.A., FR; CENTELION, FR

FD9A Lapse of provisional protection due to non-payment of fees